Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial
Hirota, Morihisa, Shimosegawa, Tooru, Kitamura, Katsuya, Takeda, Kazunori, Takeyama, Yoshifumi, Mayumi, Toshihiko, Ito, Tetsuhide, Takenaka, Mamoru, Iwasaki, Eisuke, Sawano, Hirotaka, Ishida, Etsuji, Miura, Shin, Masamune, Atsushi, Nakai, Yousuke, Mitoro, Akira, Maguchi, Hiroyuki, Kimura, Kenji, Sanuki, Tsuyoshi, Ito, Tetsuya, Haradome, Hiroki, Kozaka, Kazuto, Gabata, Toshifumi, Kataoka, Keisho, Hirota, Masahiko, Isaji, Shuji, Nakamura, Ryoji, Yamagiwa, Koki, Kayaba, Chie, Ikeda, Koji
Published in Journal of gastroenterology (01.03.2020)
Published in Journal of gastroenterology (01.03.2020)
Get full text
Journal Article
A phase I study of combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients who were previously treated with fluoropyrimidine, oxaliplatin, irinotecan, and bevacizumab
Takahashi, Naoki, Iwasa, Satoru, Tachikawa, Masanori, Fukahori, Masaru, Sudo, Kazuki, Sasaki, Yusuke, Shoji, Hirokazu, Honma, Yoshitaka, Okita, Natsuko, Takashima, Atsuo, Hamaguchi, Tetsuya, Boku, Narikazu, Shimada, Yasuhiro, Yamagiwa, Koki, Ebata, Yuka, Uchida, Yasuo, Honda, Kazufumi, Terasaki, Tetsuya, Yamada, Yasuhide
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article